Exchange Traded Concepts LLC lifted its position in shares of Ambev S.A. (NYSE:ABEV – Free Report) by 41.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,588,912 shares of the company’s stock after purchasing an additional 1,638,227 shares during the period. Exchange Traded Concepts LLC’s holdings in Ambev were worth $13,805,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in ABEV. CANADA LIFE ASSURANCE Co lifted its stake in shares of Ambev by 74.8% in the second quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company’s stock worth $32,624,000 after acquiring an additional 5,740,155 shares in the last quarter. Massachusetts Financial Services Co. MA grew its stake in Ambev by 12.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 36,058,376 shares of the company’s stock valued at $80,410,000 after purchasing an additional 3,864,844 shares in the last quarter. Marshall Wace LLP increased its holdings in Ambev by 192.7% during the 2nd quarter. Marshall Wace LLP now owns 4,208,299 shares of the company’s stock worth $10,142,000 after purchasing an additional 2,770,698 shares during the last quarter. Bank of America Corp DE increased its holdings in Ambev by 9.9% during the 2nd quarter. Bank of America Corp DE now owns 27,505,192 shares of the company’s stock worth $66,288,000 after purchasing an additional 2,479,310 shares during the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC raised its position in shares of Ambev by 12,937.7% in the 2nd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 2,385,900 shares of the company’s stock valued at $5,750,000 after purchasing an additional 2,367,600 shares in the last quarter. 8.13% of the stock is currently owned by hedge funds and other institutional investors.
Ambev Trading Down 0.5%
NYSE ABEV opened at $2.81 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 0.96. Ambev S.A. has a one year low of $2.10 and a one year high of $3.24. The company has a 50-day simple moving average of $2.93 and a 200-day simple moving average of $2.58. The firm has a market capitalization of $44.20 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 2.07 and a beta of 0.64.
Wall Street Analyst Weigh In
ABEV has been the subject of several research analyst reports. Weiss Ratings upgraded Ambev from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, March 5th. Wall Street Zen raised shares of Ambev from a “hold” rating to a “buy” rating in a report on Sunday, March 22nd. Finally, Barclays increased their price objective on shares of Ambev from $2.50 to $3.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 17th. One research analyst has rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $2.69.
Get Our Latest Research Report on ABEV
Ambev Profile
Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.
The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.
Featured Articles
Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.
